667. Deputy Cormac Devlin asked the Minister for Health her views on the potential role of the Omnipod 5 tubeless hybrid closed-loop insulin system in expanding patient choice for people with type 1 diabetes, including children, people with disabilities, needle or tube aversion, and those with high treatment burden; if she will request the HSE to examine its potential use within the national diabetes technology pathw…
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
1124. Deputy David Cullinane asked the Minister for Health when a medical product (details supplied) will be available for reimbursement; and if she will make a statement on the matter. [63710/25]
442. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 609 of 23 September 2025, to clarify if a group were excluded from the costing for the free hormone replacement therapy (HRT) scheme; if so, to outline how, given the details of an internal communication in relation to the basis for the costing (details supplied); and if she will make a statement on the matter. [62378/25]
457. Deputy Ruth Coppinger asked the Minister for Health further to Parliamentary Questions Nos. 1632 and 1633 of 4 November 2025, whether healthcare providers must indicate eligibility/ineligibility for the free HRT scheme on the prescriptions transmitted to pharmacists; and if she will make a statement on the matter. [62489/25]
965. Deputy Conor Sheehan asked the Minister for Health her plans to roll out a long-acting injection to prevent HIV, as was done by NHS England recently; and if she will make a statement on the matter. [61225/25]
1021. Deputy Michael Healy-Rae asked the Minister for Health the status of an application for medication by a person (details supplied); and if she will make a statement on the matter. [61600/25]
382. Deputy Ken O'Flynn asked the Minister for Health when her Department intends to complete the review of national policy governing the use of medications issued under special licence, as recommended by the Cork city coroner in December 2024; the expected date for finalisation of new protocols on hospital administration and clinician supervision; and if she will make a statement on the matter. [60516/25]
383. Deputy Ken O'Flynn asked the Minister for Health if her Department has directed the HSE to issue interim guidance or a temporary clinical protocol governing the administration, supervision and recording of special-licence medications in hospitals pending the completion of a full policy review; if she will publish that guidance; and if she will make a statement on the matter. [60517/25]
384. Deputy Ken O'Flynn asked the Minister for Health the number of patients currently in receipt of medications under special licence in Ireland; the number of such patients admitted to hospital in each of the past five years; and the measures being taken to ensure their medication administration is governed by clear and consistent protocols nationwide. [60518/25]
449. Deputy Malcolm Byrne asked the Minister for Health when a person (details supplied) can receive the approved drug repatha (evolocumab) as prescribed; and the current availability of the drug. [60770/25]
459. Deputy Pádraig Rice asked the Minister for Health the number of people on a waiting list for pre-exposure prophylaxis (PrEP) by clinic; and the wait time to be offered a new appointment in each clinic, in tabular form. [60783/25]
482. Deputy Martin Daly asked the Minister for Health the number that have availed of the free HRT scheme since its introduction; and if she will make a statement on the matter. [60878/25]
176. Deputy Colm Burke asked the Minister for Health to outline the number of new medicines which were submitted to the NCPE in each year between 2015 and 2025; and the number of these new medicines that were non-oncology orphan medicinal products, in tabular form; and if she will make a statement on the matter. [60301/25]
177. Deputy Colm Burke asked the Minister for Health to outline the number of non-oncology orphan medicinal products which were referred to the HSE Drugs Group by the NCPE in each year between 2015 and 2025; and to provide a breakdown of the number of successful, negative and pending reimbursement decisions for such products, in tabular form; and if she will make a statement on the matter. [60302/25]
178. Deputy Colm Burke asked the Minister for Health the average length of time taken for non-oncology orphan medicines to receive a final reimbursement decision from the HSE Drugs Group after the submission of a pricing application by a manufacturer, in tabular form; and if she will make a statement on the matter. [60303/25]
179. Deputy Colm Burke asked the Minister for Health the number of non-oncology orphan medicines which were approved by the HSE drugs group in each year from 2015 to 2025 and which did not satisfy the QALY threshold for cost-effectiveness, in tabular form; and if she will make a statement on the matter. [60304/25]
180. Deputy Colm Burke asked the Minister for Health the number of new medicines which were submitted to the NCPE in each year between 2015 and 2025; to provide a breakdown of the number of these new medicines that were non-oncology orphan medicinal products, in tabular form; and if she will make a statement on the matter. [60305/25]
181. Deputy Colm Burke asked the Minister for Health the number of non-oncology orphan medicinal products which were referred to the HSE drugs group by the NCPE in each year between 2015 and 2025; to provide a breakdown of the number of successful, negative and pending reimbursement decisions for such products, in tabular form; and if she will make a statement on the matter. [60306/25]
182. Deputy Colm Burke asked the Minister for Health the average length of time taken for non-oncology orphan medicines to receive a final reimbursement decision from the HSE drugs group after the submission of a pricing application by a manufacturer, in tabular form; and if she will make a statement on the matter. [60307/25]
183. Deputy Cathy Bennett asked the Minister for Health her proposals to ensure that patients are not forced to absorb the cost of blister-pack packaged medication, which assists patients to monitor their dosage under complex medication regimes safely and independently; and if she will make a statement on the matter. [60312/25]
1635. Deputy Ryan O'Meara asked the Minister for Health if ozempic, is available under the drugs payment scheme (DPS) or general medical services card for patients who have had it prescribed; if not, whether there are alternatives available under the DPS/GMS that a patient may instead discuss with their GP; and if she will make a statement on the matter. [57820/25]
1636. Deputy Ryan O'Meara asked the Minister for Health if ozempic, is available to a GMS patient (details supplied) who has been prescribed same by their endocrinologist and diabetes specialist; and if she will make a statement on the matter. [57821/25]
1650. Deputy Marie Sherlock asked the Minister for Health the steps she will take to engage with the market authorisation holders of medications (details supplied) to submit pricing and reimbursement applications for these drug treatments to commence in patients over 18 years of age who are diagnosed with spinal muscular atrophy; and if she will make a statement on the matter. [57883/25]
1712. Deputy Emer Currie asked the Minister for Health to consider making melatonin available through the drugs payment scheme for neurodiverse children to assist with sleeping; and if she will make a statement on the matter. [58108/25]
1758. Deputy Ruth Coppinger asked the Minister for Health the timeline for the approval of linzagolix by the National Centre for Pharmacoeconomics for the public prescription of this particular drug; and if she will make a statement on the matter. [58304/25]